Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of October 2025, with a specific reporting date of October 10, 2025. The document serves as a notification and public disclosure under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). Haleon operates as a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly a regulatory disclosure of insider share transactions. The only financial data present relates to the specific share transactions detailed below:
- Instrument: Ordinary Shares of £0.01 each (ISIN: GB00BMX86B70).
- Transaction Price: £3.4352 per share for acquired Partnership Shares.
- Matching Shares: Awarded at £Nil cost.
Material Changes
No material changes to the company's financial position, operations, or strategy are reported in this filing. The document details two specific share acquisition events by PDMRs on October 9, 2025, executed on the London Stock Exchange (XLON):
- Adrian Morris (General Counsel): Acquired 37 Partnership Shares and received 37 Matching Shares (Total volume: 74 shares).
- Tamara Rogers (Chief Marketing Officer): Acquired 37 Partnership Shares and received 37 Matching Shares (Total volume: 74 shares).
Both transactions were conducted under the Company's Share Reward Plan.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, risk factors, or contingencies. It is a routine compliance filing regarding executive shareholdings.
Investor Verification Checklist
- Verify the total number of shares held by Adrian Morris and Tamara Rogers post-transaction against previous filings.
- Confirm the current market price of Haleon ordinary shares relative to the transaction price of £3.4352.
- Review the terms of the Haleon Share Reward Plan to understand the vesting schedule for the acquired Partnership and Matching Shares.
- Note that this filing does not contain financial results; refer to the most recent Form 20-F or quarterly earnings release for financial performance.